In vivo study (time point) | Treatment | |
---|---|---|
Vein graft | Target muscle (Triceps surae muscle) | |
2 weeks | High-frequency ultrasound (n = 8 animals/group) | – |
CEUS (n = 3 animals/group) | ||
qRT-PCR (VEGF) (n = 3 animals/group) | ||
4 weeks (n = 4 animals/group) | H&E staining | – |
Immunofluorescence staining (S100, NF200) | ||
12 weeks | Nerve function (n = 8 animals/group) | High-frequency ultrasound (n = 8 animals/group) |
High-frequency ultrasound (n = 8 animals/group) | SWE and AngioPLUS examinations (n = 8 animals/group) | |
Macroscopic evaluation (n = 8 animals/group) | CEUS (n = 5 animals/group) | |
Electrophysiological recovery evaluation (n = 5 animals/group) | Macroscopic evaluation (n = 5 animals/group) | |
Morphometrical evaluation (Electron microscope) (n = 5 animals/group) | Morphometrical evaluation (H&E, Masson staining) (n = 5 animals/group) |